BCYC
BICYCLE THERAPEUTICS PLC
Key Financials
Net Income
$-218960000
↓ 29.5%
Operating Income
$-247065000
↓ 17.7%
Revenue
$72.6M
↑ 105.8%
EPS (Diluted)
$-3.16
↓ 9.0%
Total Liabilities
$107.6M
↓ 34.3%
Cash & Equivalents
$628.1M
↓ 28.6%
Shareholders' Equity
$610.0M
↓ 23.1%
Total Assets
$717.6M
↓ 25.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| PRE 14A | 4/3/2026 | View on SEC |
| 144 | 4/2/2026 | View on SEC |
| 144 | 4/2/2026 | View on SEC |
| 144 | 4/2/2026 | View on SEC |
| 144 | 4/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BCYC |
| Company Name | BICYCLE THERAPEUTICS PLC |
| CIK | 1761612 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | X0 |
| Phone | 011441223261503 |